These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12976385)

  • 1. Evaluation of vasodilator drugs in four patients with arteriosclerosis obliterans.
    TEXTER EC; REDISCH W; SHECKMAN E; FERGUSON S; STEELE JM
    Am J Med Sci; 1952 Oct; 224(4):408-12. PubMed ID: 12976385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medicamentous and surgical vasodilatation in arteriosclerosis obliterans of the lower extremity].
    STEFANICS J; PAPP S; GORGO P; RANKY L
    Zentralbl Chir; 1956; 81(4):151-63. PubMed ID: 13312575
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of vasodilator drugs in the treatment of diabetic arteriosclerosis obliterans.
    MOSS JM
    J Am Geriatr Soc; 1954 May; 2(5):284-7. PubMed ID: 13162729
    [No Abstract]   [Full Text] [Related]  

  • 4. Arteriosclerosis obliterans. I. Plethysmographic studies of peripheral circulation following administration of vasodilators.
    SAMUELS SS; TUCHMAN M
    Angiology; 1955 Feb; 6(1):1-27. PubMed ID: 14350291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thromboangiitis obliterans and arteriosclerosis obliterans; results of various methods of treatment based on the review of 104 cases].
    LEAO LE; BUENO NETO J
    Rev Paul Med; 1952 Apr; 40(4):247-56. PubMed ID: 14958160
    [No Abstract]   [Full Text] [Related]  

  • 6. A CLINICAL EVALUATION OF DIETHANOLAMINE SALT OF P-TOLYLMETHYLCARBINOL CAMPHORIC ACID (GALLOGEN) IN ARTERIOSCLEROSIS OBLITERANS.
    SCHUMER W; BATTUNG VR; FOA PP
    Angiology; 1963 Jul; 14():381-2. PubMed ID: 14047141
    [No Abstract]   [Full Text] [Related]  

  • 7. [TREATMENT OF THE CUTANEOUS ISCHEMIA OF OCCLUSIVE ARTERIOSCLEROSIS OF THE EXTREMITIES WITH A VASODILATING PREPARATION OF LOCAL ACTION].
    BUZZI A; CIBEIRA JB
    Sem Med; 1963 Dec; 123():1973-7. PubMed ID: 14128161
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of inositol in the treatment of arteriosclerosis obliterans.
    POPKIN RJ
    Angiology; 1951 Oct; 2(5):398-404. PubMed ID: 14868916
    [No Abstract]   [Full Text] [Related]  

  • 9. [The vasodilator effect of eledoisin in arteriosclerosis obliterans].
    Szám I; Kusztos D; Csapó G
    Orv Hetil; 1966 May; 107(22):1036-7. PubMed ID: 5935792
    [No Abstract]   [Full Text] [Related]  

  • 10. [Principles of conservative therapy of chronic arterial circulatory disorders].
    Heidrich H
    Internist (Berl); 1971 Sep; 12(9):377-85. PubMed ID: 4938931
    [No Abstract]   [Full Text] [Related]  

  • 11. CLINICAL AND PLETHYSMOGRAPHIC OBSERVATIONS ON THE USE OF CYCLANDELATE IN ARTERIOSCLEROSIS OBLITERANS.
    FREMONT RE
    Am J Med Sci; 1964 Feb; 247():182-95. PubMed ID: 14124708
    [No Abstract]   [Full Text] [Related]  

  • 12. Present concept of the treatment of arteriosclerosis obliterans.
    ESTES JE
    Minn Med; 1956 Apr; 39(4):203-5; passim. PubMed ID: 13309137
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of arteriosclerosis obliterans with the spleen extract.
    MARTORELL F
    Arch Int Pharmacodyn Ther; 1948 Sep; 77(3):327-36. PubMed ID: 18103987
    [No Abstract]   [Full Text] [Related]  

  • 14. Lumbar sympathectomy for arteriosclerosis obliterans; rationale and results.
    BLAIN A; CAMPBELL KN
    Surgery; 1949 Jun; 25(6):950-62. PubMed ID: 18130331
    [No Abstract]   [Full Text] [Related]  

  • 15. Sympathectomy for arteriosclerosis obliterans; rationale and results.
    BLAIN A; CAMPBELL KN; HARRIS BM
    Am Heart J; 1948 Sep; 36(3):477. PubMed ID: 18934297
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results achieved with various treatments in arteriosclerosis obliterans of the lower extremities].
    DI CIO AV
    Prensa Med Argent; 1956 Jan; 43(2):111-7. PubMed ID: 13335723
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intraarterial treatment with alpha-chymotrypsin in arteriosclerosis obliterans].
    ALTUNA DEL VALLE E; MONSERRAT CAVALLER J
    Angiologia; 1960; 12():266-9. PubMed ID: 13682774
    [No Abstract]   [Full Text] [Related]  

  • 18. [OBLITERATING ARTERIOPATHIES OF THE EXTREMITIES].
    ENJALBERT A; GEDEON A
    Toulouse Med; 1964 Feb; 65():191-205. PubMed ID: 14143539
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetraethyl ammonium chloride in the treatment of arteriosclerosis obliterans; preliminary report.
    SIMHON EM
    J Egypt Med Assoc; 1949 Apr; 32(4):355-8. PubMed ID: 18145997
    [No Abstract]   [Full Text] [Related]  

  • 20. [PERIPHERAL VASODILATOR ACTION OF MYDETON].
    SOOS S
    Orv Hetil; 1964 Jul; 105():1369-72. PubMed ID: 14181919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.